From v1 to v14: the gene expression database Bgee under the spotlight

The SIB Resource Bgee is a database for retrieval and comparison of gene expression patterns across multiple animal species. It provides an intuitive answer to the question “where is a gene expressed?” and supports research in cancer and agriculture as well as evolutionary biology.

Inferring human genomes at a fraction of the current cost promises to boost biomedical research

Thousands of genetic markers have already been robustly associated with complex human traits, such as Alzheimer’s disease, cancer, obesity, or height. A new statistical method, developed by Olivier Delaneau’s group at the SIB, offers game-changing possibilities.

Cellosaurus and Rhea join the portfolio of ELIXIR Core Data Resources

Two further resources developed by SIB Groups have been designated as of crucial importance for life sciences, as a result of the latest edition of the selection process led by ELIXIR at the European level: Cellosaurus and Rhea.

SIB resources supporting SARS-CoV-2 research

SIB experts and resources are taking part in the global effort to develop dedicated data services, analysis tools and improve knowledge sharing to fight the COVID-19 pandemic.

Season’s greetings and best wishes to our Colleagues, Members and Partners

At this special time of the year, we want to take the opportunity to thank you for your continued collaboration and support throughout 2020. Your commitment, ideas and projects keep us loving what we do each day.

The DNA regions in our brain that contribute to make us human

With only 1% difference, the human and chimpanzee protein-coding genomes are remarkably similar. Understanding the biological features that make us human is part of a fascinating debated line of research.

Machine Learning in Swiss bioinformatics: applications and challenges

A new version of ChromosomeWalk offers a gateway to an entertaining ‘genome browser’, enriched with a new selection of stories on fascinating genes – in English, French and German – as well to the PrecisionMed website for an illustrated tour of precision medicine.

Collaborating with Cellestia Biotech to launch new drug discovery program

Cellestia Biotech is initiating a new drug discovery program focused on TFs. The programme, which addresses unmet medical needs in cancer, autoimmune and inflammatory disorders (AIIDs), is launched in collaboration with Vincent Zoete